(Q38006813)

26 August 2017

Hepatitis E virus: what transplant physicians should know (English)

1 reference

26 August 2017

1 reference

Hepatitis E virus

1 reference

N Kamar

1

1 reference

26 August 2017

F Legrand-Abravanel

series ordinal

2

1 reference

26 August 2017

J Izopet

series ordinal

3

1 reference

26 August 2017

L Rostaing

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

30 April 2012

1 reference

American Journal of Transplantation

26 August 2017

1 reference

26 August 2017

12

1 reference

26 August 2017

9

1 reference

26 August 2017

2281-2287

1 reference

Hepatitis E: an emerging infection in developed countries.

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus antibodies in blood donors, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus and chronic hepatitis in organ-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Persistent carriage of hepatitis E virus in patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Genotype 3 diversity and quantification of hepatitis E virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Thermal stability of hepatitis E virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Chronic hepatitis E with cirrhosis in a kidney-transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Chronic hepatitis E infection in children with liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus excretion can be prolonged in patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Brief communication: case reports of ribavirin treatment for chronic hepatitis E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Chronic hepatitis E virus infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

No reactivation of hepatitis e virus after kidney retransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus and neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Hepatitis E in three immunocompromized children in southeastern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2012.04078.X

10.1111/J.1600-6143.2012.04078.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference